SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension
RxNorm concept 2691196, clinical drug (scd). Prescribable name: SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension, 6m through 4y (EUA).
- RxCUI
- 2691196
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2691196 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML Injectable Suspension, 6m through 4y (EUA)
Related concepts
- SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2) 0.01 MG/ML (SCDC, consists of)
- Injectable Suspension (DF, has dose form)
Linked data
NDCs
- 59267442601
- 59267442602
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2691196 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2691196 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2691196. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.